Summary
The pharmacokinetics and bioavailability of N-acetylcysteine (NAC) have been determined after its intravenous and oral administration to 6 healthy volunteers.
According to a randomized cross-over design each subject received NAC 200 mg i.v. and 400 mg p.o., and blood samples were collected for 30 h.
Reduced NAC had a volume of distribution (VSS) of 0.59 l·kg−1 and a plasma clearance of 0.84 l·h−1·kg−1. The terminal half-life after intravenous administration was 1.95 h. The oral bioavailability was 4.0%.
Based on total NAC concentration, its volume of distribution (VSS) was 0.47 l·kg−1 and its plasma clearance was 0.11 l·h−1·kg−1. The terminal half-life was 5.58 h after intravenous administration and 6.25 h after oral administration. Oral bioavailability of total NAC was 9.1%.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sheffner AL (1963) The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine. Ann NY Acad Sci 106: 298–310
Millar A, Pavia D, Agnew JE, Lopez-Vidriero MT, Lauque D, Clarke W (1985) Effect of oral N-acetylcysteine on mucus clearance. Br J Dis Chest 79: 262–266
Grassi C, Morandini GC (1976) A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis. Eur J Clin Pharmacol 9: 393–396
Multicenter Study Group (1980) Long-term acetylcysteine in chronic bronchitis. A double-blind controlled study. Eur J Respir Dis 61 [Suppl 111]: 93–108
Boman G, Bäcker U, Larsson S, Melander B, Wåhlander L (1983) Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: Report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 64: 405–415
Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT (1977) Treatment of paracetamol (acetaminophen) poisoning with N-acetalcysteine. Lancet 2: 432–437
Yarbro JW (ed) (1983) N-acetylcysteine (NAC): A significant chemoprotective adjunct. Proceedings of a symposium. Semin Oncol 10 [Suppl 1]: 1–92
Morgan LR, Holdiness MR, Gillen LE (1983) N-acetylcysteine: Its bioavailability and interactions with ifosfamide metabolites. Semin Oncol 10 [Suppl 1]: 56–61
Kågedal B, Källberg M, Mårtensson J (1984) Determination of non-protein-bound N-acetylcysteine in plasma by high-performance liquid chromatography. J Chromatogr 311: 170–175
Lewis PA, Woodward AJ, Maddock J (1985) Improved method for the determination of N-acetylcysteine in human plasma by high-performance liquid chromatography. J Chromatogr 327: 261–267
Cotgreave IA, Moldéus P (1987) Methodologies for the analysis of reduced and oxidised N-acetylcysteine in biological systems. Biopharm Drug Disp 8: 365–375
Johansson M, Westerlund D (1986) Determination of N-acetylcysteine, intact and oxidized in plasma by column liquid chromatography and post-column derivatization. J Chromatogr 385: 343–356
Sheffner AL, Medler EM, Bailey KR, Gallo DG, Mueller AJ, Sarett HP (1966) Metabolic studies with acetylcysteine. Biochem Pharmacol 15: 1523–1535
Rodenstein D, De Coster A, Gazzaniga A (1978) Pharmacokinetics of oral acetylcysteine: Absorption, binding and metabolism in patients with respiratory disorders. Clin Pharmacokinet 3: 247–254
Bonanomi L, Gazzaniga A (1980) Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis 61 [Suppl 111]: 45–51
Borgström L, Kågedal B, Paulsen O (1986) Pharmacokinetics of N-acetylcystine in man. Eur J Clin Pharmacol 31: 217–222
Hakman M, Gabrielsson J (1986) Introduction to MAXFIT: A user's guide. Dept Biopharmaceutics and Pharmacokinetics, Uppsala University, Uppsala, Sweden
Sheiner LB, Beal SL (1985) Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares. J Pharmacokinet Biopharm 13: 185–201
Riegelman S, Collier P (1980) The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 8: 509–534
Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York Basel
Cotgreave IA, Grafström RC, Moldéus P (1986) Modulation of pneumotoxicity by cellular glutathione and precursors. Bull Eur Physiopathol Respir 22: 263s-266s
Tee LBG, Boobis AR, Davies DS (1986) N-acetylcysteine for paracetamol overdose. Lancet 1: 331–332
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Olsson, B., Johansson, M., Gabrielsson, J. et al. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 34, 77–82 (1988). https://doi.org/10.1007/BF01061422
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01061422